Drugmaker GSK sees sales rise thanks to new products

Drugmaker GSK sees sales rise thanks to new products


Drugmaker GlaxoSmithKline says third-quarter sales rose 4 percent, driven by new products such as the company's Tivicay HIV treatment and Ellipta respiratory therapy. Sales increased to 7.84 billion pounds from 7.55 billion pounds in the same period last year.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога